Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21483000

J. Clin. Oncol. 2011 Jun 1 29 16 2223-9

Download in:

View as

General Info

PMID
21483000